Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

880
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
880
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

212
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Effects of Pa-pex 11 gene on penicillin production in Penicillium aurantiogriseum].

Wei sheng wu xue bao = Acta microbiologica Sinica·2010
Same author

Inhibition of lung fluid clearance and epithelial Na+ channels by chlorine, hypochlorous acid, and chloramines.

The Journal of biological chemistry·2010
Same author

Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.

Journal of medicinal chemistry·2010
Same author

Evidence for dimeric BACE-mediated APP processing.

Biochemical and biophysical research communications·2010
Same author

Involvement of mineralocorticoid receptor in high glucose-induced big mitogen-activated protein kinase 1 activation and mesangial cell proliferation.

Journal of hypertension·2010
Same author

Nanosized anatase TiO2 single crystals for enhanced photocatalytic activity.

Chemical communications (Cambridge, England)·2010

Related Experiment Video

Updated: May 20, 2025

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

2.1K

The Intersection between Immune System and Idiopathic Pulmonary Fibrosis-A Concise Review.

Hongli Liu1, Huachun Cui1, Gang Liu1

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Fibrosis (Hong Kong, China)
|March 24, 2025
PubMed
Summary

Idiopathic pulmonary fibrosis (IPF) involves complex immune cell roles in lung damage and scarring. Research is refocusing on these immune cells to understand IPF progression and develop new treatments.

Keywords:
Adaptive immunityClinical trialIPFInnate immunityMacrophage

More Related Videos

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.2K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.7K

Related Experiment Videos

Last Updated: May 20, 2025

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

2.1K
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.2K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.7K

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Fibrosis Research

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by alveolar destruction, impaired regeneration, and fibrosis.
  • Immune cells, both resident and recruited, play a critical role in IPF pathogenesis by influencing lung cells like epithelial cells, fibroblasts, and endothelial cells.
  • Understanding the immune system's complex role in IPF is crucial for developing effective therapies.

Purpose of the Study:

  • To review the historical perspectives on the immune system's involvement in IPF.
  • To analyze lessons learned from past therapeutic failures targeting immune responses in IPF.
  • To discuss current knowledge on immune cell heterogeneity and mechanisms in IPF progression.

Main Methods:

  • Literature review of historical and current research on the immune system in IPF.
  • Analysis of immune cell phenotypic transitions and mediator production in IPF pathology.
  • Identification of knowledge gaps and future research directions.

Main Results:

  • The understanding of the immune system's role in IPF has evolved significantly, moving from skepticism to renewed focus.
  • Previous immune-targeting therapies for IPF have largely failed, highlighting the complexity of immune involvement.
  • Emerging technologies provide new insights into immune cell heterogeneity and their specific functions in IPF.

Conclusions:

  • The immune system is a critical, albeit complex, player in the pathogenesis of Idiopathic Pulmonary Fibrosis.
  • Past therapeutic strategies targeting the immune system in IPF have been unsuccessful, necessitating a deeper understanding of specific immune cell functions.
  • Future research should focus on immune cell heterogeneity, phenotypic transitions, and targeted mechanisms to identify novel therapeutic targets for IPF.